Početna › Intersticijske bolesti pluća › Kansas
Kliničke studije za Intersticijske bolesti pluća u državi Kansas
13 studija za Intersticijske bolesti pluća traži sudionike na lokacijama u državi Kansas.
Gradovi u državi Kansas
Službeni tekst studije (engleski)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University of Kansas Medical Center, Kansas City
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- University of Kansas Medical Center, Kansas City
U tijeku regrutacijaFaza 3
Od 40 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA002, Kansas City
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07179380A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Kansas Medical Center, Kansas City
U tijeku regrutacijaFaza 2
Od 40 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT06968845A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Kansas City
U tijeku regrutacijaFaza 2
Od 18 do 85 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Kansas Medical Center, Kansas City
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 26. kol 2026. · NCT06388421Platform Clinical Study for Conquering Scleroderma
- University of Kansas School of Medicine, Kansas City
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- University of Kansas Medical Center, Kansas City
U tijeku regrutacijaFaza 2/3
Od 18 do 75 godina · Oba spola · Ažurirano 17. kol 2026. · NCT06328777A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- The University of Kansas Medical Center Research Institute, Kansas City
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 10. kol 2026. · NCT07175038Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- University of Kansas Medical Center, Kansas City
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 13. srp 2026. · NCT05943535Interstitial Lung Disease Research Unit Biobank
- The University of Kansas Medical Center, Kansas City
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 10. srp 2026. · NCT05392881Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
- University of Kansas Medical Center, Kansas City
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 3 godina i više · Oba spola · Ažurirano 6. svi 2026. · NCT04624490Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
- University of Kansas, Kansas City
U tijeku regrutacijaOpažajna studija
Od 18 do 90 godina · Oba spola · Ažurirano 3. svi 2024. · NCT06397677Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.